v3.22.2.2
Loss Per Share - Schedule of Potentially Issuable Common Shares not Included in Computation of Diluted Net Loss Per Share (Details) - shares
shares in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive common stock instruments outstanding (in shares) 12,756 9,954 12,756 9,954
Shares issuable upon the release of RSUs        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive common stock instruments outstanding (in shares) 4,619 2,320 4,619 2,320
Shares issuable upon exercise of stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive common stock instruments outstanding (in shares) 5,665 7,634 5,665 7,634
Shares issuable upon the exercise of the Warrant        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive common stock instruments outstanding (in shares) 2,472 0 2,472 0